Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$379.30
At close: Jun 27, 4:13 PM EDT
$379.30
0.001200.00%
After Hours: Jun 27, 4:13 PM EDT
Comments
Loading...
HCA Healthcare Analyst Ratings and Price Targets | NYSE:HCA | Benzinga
HCA Healthcare Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for HCA Healthcare Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
RBC Capital
Morgan Stanley
Barclays
Wells Fargo
B of A Securities
1calculated from analyst ratings
Analyst Ratings for HCA Healthcare
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 06/23/2025 | Buy Now | — | RBC Capital | Ben Hendrix60% | $376 → $404 | Maintains | Outperform | Get Alert |
| 06/09/2025 | Buy Now | — | Morgan Stanley | Craig Hettenbach58% | $355 → $410 | Maintains | Equal-Weight | Get Alert |
| 06/02/2025 | Buy Now | — | Barclays | Andrew Mok57% | $366 → $416 | Maintains | Overweight | Get Alert |
| 05/29/2025 | Buy Now | — | Wells Fargo | Stephen Baxter53% | $320 → $385 | Upgrade | Underweight → Equal-Weight | Get Alert |
| 05/13/2025 | Buy Now | — | B of A Securities | Kevin Fischbeck67% | $370 → $410 | Maintains | Buy | Get Alert |
| 04/28/2025 | Buy Now | — | RBC Capital | Ben Hendrix60% | $384 → $376 | Maintains | Outperform | Get Alert |
| 04/15/2025 | Buy Now | — | Baird | Michael Ha37% | $396 → $336 | Downgrade | Outperform → Neutral | Get Alert |
| 04/09/2025 | Buy Now | — | Guggenheim | Jason Cassorla49% | — | Initiates | → Neutral | Get Alert |
| 01/27/2025 | Buy Now | — | RBC Capital | Ben Hendrix60% | $405 → $384 | Maintains | Outperform | Get Alert |
| 01/27/2025 | Buy Now | — | B of A Securities | Kevin Fischbeck67% | $380 → $370 | Maintains | Buy | Get Alert |
| 01/27/2025 | Buy Now | — | Cantor Fitzgerald | Sarah James51% | $405 → $405 | Reiterates | Overweight → Overweight | Get Alert |
| 01/27/2025 | Buy Now | — | Barclays | Andrew Mok57% | $392 → $366 | Maintains | Overweight | Get Alert |
| 01/07/2025 | Buy Now | — | Keybanc | Tim Rezvan51% | $420 → $370 | Maintains | Overweight | Get Alert |
| 01/06/2025 | Buy Now | — | Truist Securities | David Macdonald65% | $430 → $390 | Maintains | Buy | Get Alert |
| 12/17/2024 | Buy Now | — | Morgan Stanley | Craig Hettenbach58% | $406 → $355 | Maintains | Equal-Weight | Get Alert |
| 12/17/2024 | Buy Now | — | JP Morgan | Benjamin Rossi67% | → $380 | Assumes | → Neutral | Get Alert |
| 11/25/2024 | Buy Now | — | Wells Fargo | Stephen Baxter53% | $400 → $320 | Downgrade | Equal-Weight → Underweight | Get Alert |
| 11/22/2024 | Buy Now | — | Raymond James | John Ransom76% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 11/08/2024 | Buy Now | — | Barclays | Andrew Mok57% | $396 → $392 | Maintains | Overweight | Get Alert |
| 11/06/2024 | Buy Now | — | Wells Fargo | Stephen Baxter53% | $395 → $400 | Maintains | Equal-Weight | Get Alert |
| 10/28/2024 | Buy Now | — | TD Cowen | Gary Taylor58% | $450 → $440 | Maintains | Buy | Get Alert |
| 10/28/2024 | Buy Now | — | Keybanc | Matthew Gillmor65% | $475 → $420 | Maintains | Overweight | Get Alert |
| 10/28/2024 | Buy Now | — | Oppenheimer | Michael Wiederhorn60% | $390 → $400 | Maintains | Outperform | Get Alert |
| 10/22/2024 | Buy Now | — | Wells Fargo | Stephen Baxter53% | $365 → $395 | Maintains | Equal-Weight | Get Alert |
| 10/11/2024 | Buy Now | — | Keybanc | Matthew Gillmor65% | → $475 | Initiates | → Overweight | Get Alert |
| 10/04/2024 | Buy Now | — | Cantor Fitzgerald | Sarah James51% | $392 → $392 | Reiterates | Overweight → Overweight | Get Alert |
| 10/01/2024 | Buy Now | — | Cantor Fitzgerald | Sarah James51% | $392 → $392 | Reiterates | Overweight → Overweight | Get Alert |
| 09/03/2024 | Buy Now | — | Morgan Stanley | Craig Hettenbach58% | → $427 | Initiates | → Equal-Weight | Get Alert |
| 08/23/2024 | Buy Now | — | RBC Capital | Ben Hendrix60% | $378 → $405 | Maintains | Outperform | Get Alert |
| 08/20/2024 | Buy Now | — | Cantor Fitzgerald | Sarah James51% | $392 → $392 | Reiterates | Overweight → Overweight | Get Alert |
| 08/19/2024 | Buy Now | — | Cantor Fitzgerald | Sarah James51% | $392 → $392 | Reiterates | Overweight → Overweight | Get Alert |
| 08/19/2024 | Buy Now | — | Truist Securities | David Macdonald65% | $390 → $430 | Maintains | Buy | Get Alert |
| 08/14/2024 | Buy Now | — | UBS | Andrew Mok57% | $405 → $438 | Maintains | Buy | Get Alert |
| 07/30/2024 | Buy Now | — | Wells Fargo | Stephen Baxter53% | $315 → $365 | Maintains | Equal-Weight | Get Alert |
| 07/25/2024 | Buy Now | — | Cantor Fitzgerald | Sarah James51% | $335 → $392 | Maintains | Overweight | Get Alert |
| 07/24/2024 | Buy Now | — | Cantor Fitzgerald | Sarah James51% | $335 → $335 | Reiterates | Overweight → Overweight | Get Alert |
| 07/24/2024 | Buy Now | — | RBC Capital | Ben Hendrix60% | $329 → $378 | Maintains | Outperform | Get Alert |
| 07/24/2024 | Buy Now | — | Barclays | Andrew Mok57% | $376 → $396 | Maintains | Overweight | Get Alert |
| 07/24/2024 | Buy Now | — | Leerink Partners | — | $367 → $396 | Maintains | Outperform | Get Alert |
| 07/24/2024 | Buy Now | — | Oppenheimer | Michael Wiederhorn60% | $345 → $390 | Maintains | Outperform | Get Alert |
| 07/24/2024 | Buy Now | — | Truist Securities | David Macdonald65% | $375 → $390 | Maintains | Buy | Get Alert |
| 07/10/2024 | Buy Now | — | Barclays | Andrew Mok57% | $367 → $376 | Maintains | Overweight | Get Alert |
| 07/10/2024 | Buy Now | — | Cantor Fitzgerald | Sarah James51% | $335 → $335 | Reiterates | Overweight → Overweight | Get Alert |
| 07/09/2024 | Buy Now | — | Cantor Fitzgerald | Sarah James51% | $335 → $335 | Reiterates | Overweight → Overweight | Get Alert |
| 07/02/2024 | Buy Now | — | Cantor Fitzgerald | Sarah James51% | $335 → $335 | Reiterates | Overweight → Overweight | Get Alert |
| 06/28/2024 | Buy Now | — | Deutsche Bank | Pito Chickering67% | $359 → $375 | Maintains | Buy | Get Alert |
| 05/30/2024 | Buy Now | — | JP Morgan | Lisa Gill55% | $327 → $332 | Maintains | Neutral | Get Alert |
| 05/30/2024 | Buy Now | — | Baird | Michael Ha37% | → $396 | Initiates | → Outperform | Get Alert |
| 04/30/2024 | Buy Now | — | TD Cowen | Gary Taylor58% | $371 → $360 | Maintains | Buy | Get Alert |
| 04/29/2024 | Buy Now | — | Barclays | Andrew Mok57% | $356 → $367 | Maintains | Overweight | Get Alert |
| 04/29/2024 | Buy Now | — | RBC Capital | Ben Hendrix60% | $322 → $329 | Maintains | Outperform | Get Alert |
| 04/29/2024 | Buy Now | — | Oppenheimer | Michael Wiederhorn60% | $330 → $345 | Maintains | Outperform | Get Alert |
| 04/12/2024 | Buy Now | — | Deutsche Bank | Pito Chickering67% | $330 → $359 | Maintains | Buy | Get Alert |
| 04/10/2024 | Buy Now | — | Cantor Fitzgerald | Sarah James51% | $335 → $335 | Reiterates | Overweight → Overweight | Get Alert |
| 03/28/2024 | Buy Now | — | Wells Fargo | Stephen Baxter53% | $303 → $315 | Maintains | Equal-Weight | Get Alert |
| 03/06/2024 | Buy Now | — | Barclays | Andrew Mok57% | → $356 | Initiates | → Overweight | Get Alert |
| 03/05/2024 | Buy Now | — | Cantor Fitzgerald | Sarah James51% | $335 → $335 | Reiterates | Overweight → Overweight | Get Alert |
| 01/31/2024 | Buy Now | — | Raymond James | John Ransom76% | $300 → $330 | Maintains | Outperform | Get Alert |
| 01/31/2024 | Buy Now | — | RBC Capital | Ben Hendrix60% | $308 → $322 | Maintains | Outperform | Get Alert |
| 01/31/2024 | Buy Now | — | Truist Securities | David Macdonald65% | $320 → $345 | Maintains | Buy | Get Alert |
| 01/24/2024 | Buy Now | — | Raymond James | John Ransom76% | $280 → $300 | Maintains | Outperform | Get Alert |
| 01/19/2024 | Buy Now | — | Cantor Fitzgerald | Sarah James51% | $315 → $315 | Reiterates | Overweight → Overweight | Get Alert |
| 01/17/2024 | Buy Now | — | Oppenheimer | Michael Wiederhorn60% | → $315 | Reiterates | Outperform → Outperform | Get Alert |
| 01/04/2024 | Buy Now | — | Bernstein | Lance Wilkes53% | → $301 | Downgrade | Outperform → Market Perform | Get Alert |
| 12/11/2023 | Buy Now | — | Goldman Sachs | Jamie Perse63% | — | Downgrade | Buy → Neutral | Get Alert |
| 11/17/2023 | Buy Now | — | JP Morgan | Samik Chatterjee71% | $313 → $265 | Maintains | Neutral | Get Alert |
| 11/10/2023 | Buy Now | — | Stephens & Co. | Scott Fidel69% | → $280 | Reiterates | Overweight → Overweight | Get Alert |
| 10/30/2023 | Buy Now | — | Goldman Sachs | Jamie Perse63% | $329 → $281 | Maintains | Buy | Get Alert |
| 10/26/2023 | Buy Now | — | Wells Fargo | Stephen Baxter53% | $267 → $254 | Maintains | Equal-Weight | Get Alert |
| 10/25/2023 | Buy Now | — | Truist Securities | David Macdonald65% | $340 → $300 | Maintains | Buy | Get Alert |
| 10/25/2023 | Buy Now | — | Mizuho | Ann Hynes86% | $325 → $275 | Maintains | Buy | Get Alert |
| 10/25/2023 | Buy Now | — | RBC Capital | Ben Hendrix60% | $315 → $284 | Maintains | Outperform | Get Alert |
| 10/25/2023 | Buy Now | — | Stephens & Co. | Scott Fidel69% | $300 → $280 | Maintains | Overweight | Get Alert |
| 10/25/2023 | Buy Now | — | Citigroup | Jason Cassorla49% | $324 → $279 | Maintains | Buy | Get Alert |
| 10/25/2023 | Buy Now | — | Raymond James | John Ransom76% | $320 → $280 | Maintains | Outperform | Get Alert |
| 10/20/2023 | Buy Now | — | Wells Fargo | Stephen Baxter53% | $275 → $267 | Maintains | Equal-Weight | Get Alert |
| 09/14/2023 | Buy Now | — | Cantor Fitzgerald | Sarah James51% | → $315 | Reiterates | Overweight → Overweight | Get Alert |
| 09/13/2023 | Buy Now | — | RBC Capital | Ben Hendrix60% | → $315 | Reiterates | Outperform → Outperform | Get Alert |
| 07/28/2023 | Buy Now | — | Credit Suisse | A.J. Rice70% | $311 → $316 | Maintains | Outperform | Get Alert |
| 07/28/2023 | Buy Now | — | Oppenheimer | Michael Wiederhorn60% | $310 → $315 | Maintains | Outperform | Get Alert |
| 07/11/2023 | Buy Now | — | Mizuho | Ann Hynes86% | $305 → $325 | Maintains | Buy | Get Alert |
| 06/28/2023 | Buy Now | — | Barclays | Steve Valiquette52% | $275 → $300 | Maintains | Equal-Weight | Get Alert |
| 06/20/2023 | Buy Now | — | Truist Securities | David Macdonald65% | $325 → $340 | Maintains | Buy | Get Alert |
| 05/16/2023 | Buy Now | — | Mizuho | Ann Hynes86% | $298 → $305 | Maintains | Buy | Get Alert |
| 05/10/2023 | Buy Now | — | Argus Research | David Toung68% | $285 → $310 | Maintains | Buy | Get Alert |
| 04/25/2023 | Buy Now | — | Wells Fargo | Stephen Baxter53% | $243 → $275 | Maintains | Equal-Weight | Get Alert |
| 04/25/2023 | Buy Now | — | Bernstein | Lance Wilkes53% | $310 → $345 | Maintains | Outperform | Get Alert |
| 04/25/2023 | Buy Now | — | Barclays | Steve Valiquette52% | $256 → $275 | Maintains | Equal-Weight | Get Alert |
| 04/24/2023 | Buy Now | — | Truist Securities | David Macdonald65% | $310 → $325 | Maintains | Buy | Get Alert |
| 04/24/2023 | Buy Now | — | Jefferies | Brian Tanquilut46% | $325 → $350 | Maintains | Buy | Get Alert |
| 04/24/2023 | Buy Now | — | Deutsche Bank | Pito Chickering67% | $280 → $310 | Maintains | Buy | Get Alert |
| 04/24/2023 | Buy Now | — | Loop Capital | Joseph France64% | $285 → $320 | Maintains | Buy | Get Alert |
| 04/24/2023 | Buy Now | — | TD Cowen | Gary Taylor58% | $292 → $326 | Maintains | Outperform | Get Alert |
| 04/24/2023 | Buy Now | — | B of A Securities | Kevin Fischbeck67% | $294 → $323 | Maintains | Buy | Get Alert |
| 04/24/2023 | Buy Now | — | Raymond James | John Ransom76% | $300 → $320 | Maintains | Outperform | Get Alert |
| 04/24/2023 | Buy Now | — | RBC Capital | Ben Hendrix60% | $283 → $315 | Maintains | Outperform | Get Alert |
| 04/24/2023 | Buy Now | — | Credit Suisse | A.J. Rice70% | $282 → $311 | Maintains | Outperform | Get Alert |
| 04/24/2023 | Buy Now | — | Oppenheimer | Michael Wiederhorn60% | $270 → $310 | Maintains | Outperform | Get Alert |
| 04/24/2023 | Buy Now | — | Citigroup | Jason Cassorla49% | $293 → $324 | Maintains | Buy | Get Alert |
| 04/21/2023 | Buy Now | — | Stephens & Co. | Scott Fidel69% | → $283 | Reiterates | → Overweight | Get Alert |
FAQ
What is the target price for HCA Healthcare (HCA) stock?
The latest price target for HCA Healthcare (NYSE:HCA) was reported by RBC Capital on June 23, 2025. The analyst firm set a price target for $404.00 expecting HCA to rise to within 12 months (a possible 6.51% upside). 45 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for HCA Healthcare (HCA)?
The latest analyst rating for HCA Healthcare (NYSE:HCA) was provided by RBC Capital, and HCA Healthcare maintained their outperform rating.
When was the last upgrade for HCA Healthcare (HCA)?
The last upgrade for HCA Healthcare Inc happened on May 29, 2025 when Wells Fargo raised their price target to $385. Wells Fargo previously had an underweight for HCA Healthcare Inc.
When was the last downgrade for HCA Healthcare (HCA)?
The last downgrade for HCA Healthcare Inc happened on April 15, 2025 when Baird changed their price target from $396 to $336 for HCA Healthcare Inc.
When is the next analyst rating going to be posted or updated for HCA Healthcare (HCA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of HCA Healthcare, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for HCA Healthcare was filed on June 23, 2025 so you should expect the next rating to be made available sometime around June 23, 2026.
Is the Analyst Rating HCA Healthcare (HCA) correct?
While ratings are subjective and will change, the latest HCA Healthcare (HCA) rating was a maintained with a price target of $376.00 to $404.00. The current price HCA Healthcare (HCA) is trading at is $379.30, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
